Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPOM: Benzydamine and Bocaliner for Prevention of Oral Mucositis
NCT05338398Phase 2Enrolling by invitation
- Sponsor
- E2Bio Life Sciences
- Start
- Apr 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of benzydamine in oral mucositis (OM), sponsored by E2Bio Life Sciences. Started Apr 2022; status: enrolling by invitation.
02
Drugs
benzydamine
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT05338398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05338398.